Revilab SL 09 is a next-generation peptide complex designed specifically for men. This advanced formula targets the key systems that matter most: sexual, hormonal, genitourinary, and neuroendocrine health.
Subscribe to mailing and get the latest news and discounts of our store.>
An open letter: the 2024 year’s results
Dear Friends and honorable partners!
In the leadup to Christmas and the New Year, we would like to summarize the results of this successful and eventful year. 2024 has become the year of new challenges and considerable trials for us. In some areas we had to face difficulties, which, nevertheless, opened new prospects for growth and development. We not only successfully overcame them, but took important steps to strengthen our position as well.
In the current year, we have introduced innovative peptide complexes for men and women — GPL® Man and GPL® Femme — which are designed to facilitate recovery from challenging stresses, including those associated with the outcomes from COVID-19.
I am proud to share our plans for 2025. We are preparing a line of five new products — Omega, Collagen, Joint, Brain and Protect. An updated Hair care line is currently in development, as well as a series of mesotels for external application. Chondro2mix cream for joint skin and updated Peptide complexes will become available soon. Additional forthcoming releases include an updated Peptides product catalog in English, reflecting all current changes and developments.
These achievements have been made possible by the contributions of our partners, heads of dealerships and everyone who supports the company’s ideas and trusts our products. Thank you for your support and cooperation! Together, through our expertise and strong partnerships, we are creating a world of health and beauty.
Wishing you a Merry Christmas and a Happy New Year! May the year 2025 bring you joy and inspiration, and may all your dreams come to fruition.
With wishes for success and goodness,
Head of the Peptides team in Europe,
Viacheslav Vasilenko
Kidney diseases are a global health challenge, affecting 10-20% of the population and significantly impacting quality of life. Therefore, our new research article in the SIC project focuses on the use of peptide bioregulators (such as Pielotax, Ovagen, and Renefort) in the prevention and treatment of kidney pathologies.
We are pleased to invite you to explore a new article from the Scientific Information Center on male health and peptide bioregulators — Application of peptide bioregulators to maintain the function of the male reproductive system.
In a recently conducted scientific study within the framework of the SIC project «Clinical and experimental studies of the efficacy of vascular peptides», an in-depth review of the primary aspects of the aforementioned topic will be conducted. The aspects addressed include:
